लोड हो रहा है...

CDK4/6 inhibition in breast cancer: current practice and future directions

The cyclin D/cyclin-dependent kinases 4 and 6 (CDK4/6)–retinoblastoma protein (RB) pathway plays a key role in the proliferation of both normal breast epithelium and breast cancer cells. A strong rationale for inhibiting CDK4/6 in breast cancers has been present for many years. However, potent and s...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Sonia Pernas, Sara M. Tolaney, Eric P. Winer, Shom Goel
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publishing 2018-07-01
श्रृंखला:Therapeutic Advances in Medical Oncology
ऑनलाइन पहुंच:https://doi.org/10.1177/1758835918786451
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!